Drug intelligence / Profile preview

injectable platelet-rich fibrin

Development stage
Phase 4
Lead developer
Medical University of Bialystok
Modality
Cell Therapies
Administration
Intralesional, Intraarticular, Subcutaneous, Topical
01

Overview

Injectable platelet-rich fibrin (i-PRF) is a second-generation autologous blood concentrate developed to overcome the limitations of solid PRF. It is obtained by centrifuging a patient's whole blood at lower speeds and for shorter durations than traditional PRF, resulting in a liquid formulation that remains injectable for a limited time before forming a fibrin clot. i-PRF contains a high concentration of platelets, leukocytes, and mesenchymal stem cells, which gradually release growth factors such as TGF-β, PDGF, and VEGF. It is primarily used in regenerative dentistry (e.g., periodontitis, wound healing, and bone grafting) and orthopedics to promote tissue healing and reduce inflammation.

Brand names
IDRIA B
Other names
i-PRFliquid platelet-rich fibrininjectable PRF
02

Targets

IGF-1R (Insulin-like growth factor 1 receptor)PDGFRA (Platelet-derived growth factor receptor alpha)TGFBR (TGF-beta receptor)

Beyond the preview

Go deeper on injectable platelet-rich fibrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on injectable platelet-rich fibrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call